Pharmacotherapy of heart failure in the elderly: Adverse events

Heart Failure Reviews

Volumn 17, Issue 4-5, 2012, Pages 589-595

  Rich, Michael W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adverse events; Drug therapy; Elderly; Heart failure

Indexed keywords

ALDOSTERONE ANTAGONIST; ALOE VERA EXTRACT; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DABIGATRAN; DIGOXIN; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DRONEDARONE; EPLERENONE; HYDRALAZINE; HYPERICUM PERFORATUM EXTRACT; ISOSORBIDE DINITRATE; LOOP DIURETIC AGENT; METOPROLOL; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; SENNA EXTRACT; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TRIAMTERENE; UNINDEXED DRUG; VERAPAMIL; WARFARIN;

ABDOMINAL DISCOMFORT; AGED; AGING; ANGINA PECTORIS; ANOREXIA; BRADYCARDIA; CHRONIC KIDNEY DISEASE; CHRONIC LUNG DISEASE; CONSTIPATION; CORONARY ARTERY DISEASE; COUGHING; CREATININE BLOOD LEVEL; DIARRHEA; DIZZINESS; DRUG ANTAGONISM; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG POTENTIATION; EDEMA; ELECTROLYTE DISTURBANCE; FALLING; FATIGUE; FLUSHING; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GYNECOMASTIA; HEART AMYLOIDOSIS; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART PALPITATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERCALCEMIA; HYPERKALEMIA; HYPERTENSION; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; HYPOTENSION; KIDNEY FUNCTION; MENTAL DISEASE; NAUSEA; POLYPHARMACY; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; RISK REDUCTION; SIDE EFFECT; SYNCOPE; TACHYCARDIA; TASTE DISORDER; VISUAL DISORDER; WEAKNESS;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR AGENTS; DRUG INTERACTIONS; DRUG THERAPY; HEART FAILURE; HUMANS; POLYPHARMACY; RISK FACTORS;

EID: 84862687332     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-011-9263-1     Document Type: Review

References (46)

1. S Stegemann F Ecker M Maio, et al. 2010 Geriatric drug therapy: neglecting the inevitable majority Ageing Res Rev 9 384 398 20478411 10.1016/j.arr.2010.04.005
2. U Klotz 2009 Pharmacokinetics and drug metabolism in the elderly Drug Metab Rev 41 67 76 19514965 10.1080/03602530902722679 1:CAS:528: DC%2BD1MXnsVagsrc%3D
3. JB Braunstein GF Anderson G Gerstenblith, et al. 2003 Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure J Am Coll Cardiol 42 1226 1233 14522486 10.1016/S0735-1097(03)00947-1
4. MW Rich 2005 Heart failure in the oldest patients: the impact of comorbid conditions Am J Geriatr Card 14 134 141 10.1111/j.1076-7460.2005.03890.x
5. LA Stevens AS Levey 2005 Chronic kidney disease in the elderly-how to assess risk N Engl J Med 352 2122 2124 15901867 10.1056/NEJMe058035 1:CAS:528:DC%2BD2MXkt1Kktr4%3D
6. JT Hanlon SL Aspinall TP Semla, et al. 2009 Consensus guidelines for oral dosing of primarily renally cleared medications in older adults J Am Geriatr Soc 57 335 340 19170784 10.1111/j.1532-5415.2008.02098.x
7. XJ Zhou D Rakheja X Yu R Saxena ND Vaziri FG Silva 2008 The aging kidney Kidney Internat 74 6 710 720 10.1038/ki.2008.319 1:CAS:528:DC%2BD1cXhtVGgtbjM
8. WL Kenney P Chiu 2001 Influence of age on thirst and fluid intake Med Sci Sports Exerc 33 1524 1532 11528342 10.1097/00005768-200109000-00016 1:STN:280:DC%2BD3MvosF2rtA%3D%3D
9. Shem S (1979) House of God. Random House, Inc, New York
10. MA Steinman JT Hanlon 2010 Managing medications in clinically complex elders. "There's got to be a happy medium" JAMA 304 1592 1601 20940385 10.1001/jama.2010.1482 1:CAS:528:DC%2BC3cXhtlWisLjM
11. B Pitt R Segal FA Martinez, et al. 1997 Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) Lancet 349 747 752 9074572 10.1016/S0140-6736(97) 01187-2 1:CAS:528:DyaK2sXitlOksLk%3D
12. B Pitt PA Poole-Wilson R Segal, et al. 2000 Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomized trial-the Losartan Heart Failure Survival Study ELITE II Lancet 355 1582 1587 10821361 10.1016/S0140-6736(00)02213-3 1:CAS:528:DC%2BD3cXjs1Glurc%3D
13. DW Cockcroft MH Gault 1976 Prediction of creatinine clearance from serum creatinine Nephron 16 31 41 1244564 10.1159/000180580 1:STN:280: DyaE28%2FnsF2isw%3D%3D
14. AS Levey JP Bosch JB Lewis 1999 A more accurate method to estimate glomerular filtration rate from serum creatinine: a new predication equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 461 470 10075613 1:CAS:528:DyaK1MXitFChs7k%3D
15. BM Massie PW Armtrong JG Cleland, et al. 2001 Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival Arch Intern Med 161 165 171 11176729 10.1001/archinte.161.2.165 1:CAS:528:DC%2BD3MXps1Sjtg%3D%3D
16. M Packer PA Poole-Wilson PW Armstrong, et al. 1999 Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group Circulation 100 2312 2318 10587334 1:CAS:528:DC%2BD3cXhsVWltA%3D%3D
17. DN Juurlink MM Mamdani DS Lee, et al. 2004 Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study N Engl J Med 351 543 551 15295047 10.1056/NEJMoa040135 1:CAS:528:DC%2BD2cXmtF2rtb0%3D
18. KP Tamirisa KD Aaronson TM Koelling 2004 Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure Am Heart J 148 971 978 15632880 10.1016/j.ahj.2004.10.005 1:CAS:528:DC%2BD2cXhtVKltrbN
19. GD Braunstein 2007 Clinical practice. Gynecomastia N Engl J Med 357 1229 1237 17881754 10.1056/NEJMcp070677 1:CAS:528:DC%2BD2sXhtVOhtbvM
20. SA Hunt WT Abraham MH Chin, et al. 2009 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults Circulation 119 e391 e479 19324966 10.1161/CIRCULATIONAHA.109. 192065
21. EG Lakatta D Levy 2003 Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease Circulation 107 346 354 12538439 10.1161/01.CIR.0000048893.62841. F7
22. EG Lakatta 2003 Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging Circulation 107 490 497 12551876 10.1161/01.CIR. 0000048894.99865.02
23. CG Hanratty P McGlinchey GD Johnston AP Passmore 2000 Differential pharmacokinetics of digoxin in elderly patients Drugs Ageing 17 353 362 10.2165/00002512-200017050-00003 1:CAS:528:DC%2BD3cXovVGhu70%3D
24. A Ahmed MW Rich TE Love, et al. 2006 Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial Eur Heart J 27 178 186 16339157 10.1093/eurheartj/ehi687 1:CAS:528:DC%2BD28XhsVegtbs%3D
25. MW Rich F McSherry WO Williford S Yusuf 2001 Digitalis Investigation Group. Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study J Am Coll Cardiol 38 806 813 11527638 10.1016/S0735-1097(01)01442-5 1:CAS:528:DC%2BD3MXntlaitLY%3D
26. J Weil R Sen Gupta H Herfarth 2004 Nonocclusive mesenteric ischemia induced by digitalis Int J Colorectal Dis 19 277 280 14614629 10.1007/s00384-003-0552-6
27. DC Schaefer LJ Cheskin 1998 Constipation in the elderly Am Fam Phys 58 907 914 1:STN:280:DyaK1cvktVynsg%3D%3D
28. DW Kitzman JM Gardin JS Gottdiener, et al. 2001 Importance of heart failure with preserved systolic function in patients ≥ 65 years of age. CHS Research Group. Cardiovascular Health Study Am J Cardiol 87 413 419 11179524 10.1016/S0002-9149(00)01393-X 1:STN:280:DC%2BD3M3gsV2msw%3D%3D
29. Heart Failure Society of America 2010 Comprehensive heart failure practice guidelines. Heart failure in patients with preserved ejection fraction J Cardiac Fail 16 e73 e97 10.1016/j.cardfail.2010.04.005
30. TS Tsang BJ Gersh CP Appleton, et al. 2002 Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women J Am Coll Cardiol 40 1636 1644 12427417 10.1016/S0735-1097(02)02373-2
31. RM Seymour PA Routledge 1998 Important drug-drug interactions in the elderly Drugs Ageing 12 485 494 10.2165/00002512-199812060-00006 1:CAS:528:DyaK1cXkt1Kkt70%3D
32. A Whelton 1999 Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications Am J Med 106 13S 24S 10390124 10.1016/S0002-9343(99)00113-8 1:CAS:528:DyaK1MXjvFOns74%3D
33. J Page D Henry 2000 Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem Arch Int Med 160 777 784 10.1001/archinte.160.6.777 1:CAS:528: DC%2BD3cXisVClsbc%3D
34. P Vassallo RG Trohman 2007 Prescribing amiodarone: an evidence-based review of clinical indications JAMA 298 1312 1322 17878423 10.1001/jama.298.11. 1312 1:CAS:528:DC%2BD2sXhtVygsb7I
35. SC Shirolkar M Fiuzat RC Becker 2010 Dronedarone and vitamin K antagonists: a review of drug-drug interactions Am Heart J 160 577 582 20934550 10.1016/j.ahj.2010.07.008 1:CAS:528:DC%2BC3cXht1Kqtr7I
36. CI Obialo EO Ofili T Mirza 2002 Hyperkalemia in congestive heart failure patients aged 63 to 85 years with subclinical renal disease Am J Cardiol 90 663 665 12231103 10.1016/S0002-9149(02)02581-X 1:CAS:528:DC%2BD38XmvVCktb4%3D
37. DM Qato GC Alexander RM Conti M Johnson P Schumm ST Lindau 2008 Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States JAMA 300 2867 2878 19109115 10.1001/jama.2008.892 1:CAS:528:DC%2BD1MXmtlGitQ%3D%3D
38. PA Cohen E Ernst 2010 Safety of herbal supplements: a guide for cardiologists Cardiovasc Therapeut 28 246 253 10.1111/j.1755-5922.2010.00193.x
39. P Gastelurrutia SI Benrimoj J Espejo L Tuneu MA Mangues A Bayes-Genis 2011 Negative clinical outcomes associated with drug-related problems in heart failure (HF) outpatients: impact of a pharmacist in a multidisciplinary HF clinic J Cardiac Fail 17 217 223 10.1016/j.cardfail.2010.10.009
40. TT Fulmer PH Feldman TS Kim, et al. 1999 An intervention study to enhance medication compliance in community-dwelling elderly individuals J Gerontol Nursing 25 6 14 1:STN:280:DC%2BD3c7ns1Cnsw%3D%3D
41. EG Lakatta D Levy 2003 Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part 1: aging arteries: a "set up" for vascular disease Circulation 107 139 146 12515756 10.1161/01.CIR. 0000048892.83521.58
42. V Gupta LA Lipsitz 2007 Orthostatic hypotension in the elderly: diagnosis and treatment Am J Med 120 841 847 17904451 10.1016/j.amjmed.2007.02.023
43. A Poluri J Mores DB Cook TW Findley A Cristian 2005 Fatigue in the elderly population Phys Med Rehab Clin North Am 16 91 108 10.1016/j.pmr.2004.06. 006
44. JY Wick J LaFleur 2007 Fatigue: implications for the elderly Consult Pharm 22 566 578 17714001 10.4140/TCP.n.2007.566
45. JY Choi JC Morris CY Hsu 1998 Aging and cerebrovascular disease Neurol Clin 16 687 711 9666045 10.1016/S0733-8619(05)70089-X 1:STN:280: DyaK1czjt1Oltw%3D%3D
46. A Cherubini DT Lowenthal E Paran P Mecocci LS Williams U Senin 2007 Hypertension and cognitive function in the elderly Am J Therapeut 14 533 554 10.1097/MJT.0b013e3180ed6b8f